Contact this trialFirst, we need to learn more about you.
Anthelmintic
Pyrvinium Pamoate for Pancreatic Cancer
Recruiting1 awardPhase 1
Philadelphia, Pennsylvania
This trial is testing pyrvinium pamoate, a medication that may slow down the growth of pancreatic cancer. It targets patients whose cancer cannot be removed by surgery. The goal is to see if this treatment can help these patients live longer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service